famotidine

Generic: famotidine

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name famotidine
Generic Name famotidine
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

famotidine 10 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-739
Product ID 63323-739_241710d5-bcef-4852-a09c-0e681250e6aa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075813
Listing Expiration 2026-12-31
Marketing Start 2001-03-15

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323739
Hyphenated Format 63323-739

Supplemental Identifiers

RxCUI
1743833
UPC
0363323739416
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name famotidine (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA075813 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-USE in 1 TRAY (63323-739-16) / 2 mL in 1 VIAL, SINGLE-USE (63323-739-41)
source: ndc

Packages (1)

Ingredients (1)

famotidine (10 mg/mL)

Linked Drug Pages (2)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "241710d5-bcef-4852-a09c-0e681250e6aa", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0363323739416"], "unii": ["5QZO15J2Z8"], "rxcui": ["1743833"], "spl_set_id": ["ce533636-cc9b-45d0-87a6-5390377ff28a"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-USE in 1 TRAY (63323-739-16)  / 2 mL in 1 VIAL, SINGLE-USE (63323-739-41)", "package_ndc": "63323-739-16", "marketing_start_date": "20010315"}], "brand_name": "Famotidine", "product_id": "63323-739_241710d5-bcef-4852-a09c-0e681250e6aa", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "63323-739", "generic_name": "Famotidine", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "10 mg/mL"}], "application_number": "ANDA075813", "marketing_category": "ANDA", "marketing_start_date": "20010315", "listing_expiration_date": "20261231"}